BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29367427)

  • 1. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.
    Saulnier PJ; Gand E; Velho G; Mohammedi K; Zaoui P; Fraty M; Halimi JM; Roussel R; Ragot S; Hadjadj S;
    Diabetes Care; 2017 Mar; 40(3):367-374. PubMed ID: 27998909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study.
    Maple-Brown LJ; Hughes JT; Ritte R; Barzi F; Hoy WE; Lawton PD; Jones GRD; Death E; Simmonds A; Sinha AK; Cherian S; Thomas MAB; McDermott R; Brown ADH; O'Dea K; Jerums G; Cass A; MacIsaac RJ
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):993-1004. PubMed ID: 27076636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
    J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study.
    Ekinci EI; Barr ELM; Barzi F; Hughes JT; Lawton PD; Jones GRD; Hoy W; Cass A; Thomas M; Sinha A; Jerums G; O'Dea K; MacIsaac RJ; Maple-Brown LJ
    J Diabetes Complications; 2019 May; 33(5):343-349. PubMed ID: 30904420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.
    Majoni SW; Barzi F; Hoy W; MacIsaac RJ; Cass A; Maple-Brown L; Hughes JT
    BMC Nephrol; 2020 Dec; 21(1):523. PubMed ID: 33261565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sTNFR1 and BNP Levels with Diminished Estimated Glomerular Filtration Rate in Type 2 Diabetic Egyptian Patients.
    Mokhtar ER; M E; Hassan MA; Abou-ELHassan HA; Alanany MG; Hasuna MA
    Egypt J Immunol; 2018 Jan; 25(1):57-69. PubMed ID: 30242998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
    Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
    Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
    Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.
    Chang LH; Hwu CM; Lin YC; Huang CC; Won JGS; Chen HS; Lin LY
    Endocr Pract; 2020 Oct; 26(10):1115-1124. PubMed ID: 33471713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.
    Chang LH; Hwu CM; Chu CH; Lin YC; Huang CC; You JY; Chen HS; Lin LY
    J Endocrinol Invest; 2021 Dec; 44(12):2609-2619. PubMed ID: 33834419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfiltration in Indigenous Australians with and without diabetes.
    Ekinci EI; Hughes JT; Chatfield MD; Lawton PD; Jones GR; Ellis AG; Cass A; Thomas M; MacIsaac RJ; O'Dea K; Jerums G; Maple-Brown LJ
    Nephrol Dial Transplant; 2015 Nov; 30(11):1877-84. PubMed ID: 26142395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.